Product/Composition:- | Perphenazine Tablets |
---|---|
Strength:- | 2 mg, 4 mg, 8 mg, 16 mg |
Form:- | Oral Tablets |
Reference Brands:- | Trilafon®(US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Perphenazine is a typical antipsychotic that works by blocking dopamine D2 receptors in the brain, helping to reduce psychotic symptoms such as hallucinations, delusions, and thought disorders. It is primarily used for the treatment of schizophrenia and other psychotic conditions. Additionally, it may be used in low doses to control severe nausea and vomiting.
Perphenazine tablets are FDA-approved in the United States for the treatment of schizophrenia and for the control of severe nausea and vomiting. In the EU, their availability varies by country under national procedures, primarily indicated for psychotic disorders. Regulatory requirements include GMP compliance, detailed clinical data on extrapyramidal side effects, and clear psychiatric risk labeling. U.S. submissions must follow FDA labeling guidelines and include pharmacovigilance plans. EU applications may require harmonization with national formularies. To explore dossier-ready Perphenazine tablets, alternative formulations, and global suppliers, visit Pharmatradz.com — your trusted B2B pharma sourcing platform.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications